Cosmos Pharmaceutical Corp
TSE:3349
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Cosmos Pharmaceutical Corp
Cash Interest Paid
Cosmos Pharmaceutical Corp
Cash Interest Paid Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash Interest Paid | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Cosmos Pharmaceutical Corp
TSE:3349
|
Cash Interest Paid
¥379m
|
CAGR 3-Years
99%
|
CAGR 5-Years
43%
|
CAGR 10-Years
19%
|
|
|
Sundrug Co Ltd
TSE:9989
|
Cash Interest Paid
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Tsuruha Holdings Inc
TSE:3391
|
Cash Interest Paid
¥2.4B
|
CAGR 3-Years
34%
|
CAGR 5-Years
36%
|
CAGR 10-Years
66%
|
|
|
Welcia Holdings Co Ltd
TSE:3141
|
Cash Interest Paid
¥867m
|
CAGR 3-Years
18%
|
CAGR 5-Years
16%
|
CAGR 10-Years
15%
|
|
|
S
|
Sugi Holdings Co Ltd
TSE:7649
|
Cash Interest Paid
¥593m
|
CAGR 3-Years
249%
|
CAGR 5-Years
103%
|
CAGR 10-Years
42%
|
|
|
MatsukiyoCocokara & Co
TSE:3088
|
Cash Interest Paid
¥50m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
7%
|
CAGR 10-Years
4%
|
|
Cosmos Pharmaceutical Corp
Glance View
In the bustling landscape of Japan's healthcare and beauty industry, Cosmos Pharmaceutical Corp. stands out as a compelling story of strategic ambition and adaptive growth. Established in 1976, the company emerged in Fukuoka, swiftly evolving from a traditional pharmacy into one of the country's most recognized chains of drugstores. Cosmos carved its niche by blending the conveniences of modern retailing with a diverse array of pharmaceutical, health, and personal care products. It's not merely a matter of selling medication; Cosmos transformed the drugstore experience, offering a comprehensive range of products including cosmetics, daily essentials, and food items, which cater to the holistic needs of its customers. This diversification strategy bolsters revenue streams and mitigates risks associated with dependency on any single product category. The company's financial success is further driven by its efficient use of technology and economy of scale. Cosmos Pharmaceutical masterfully implements IT solutions and logistics optimization to manage its expansive network of stores, which number in the thousands across Japan. This not only reduces operational costs but also ensures timely restocking, enhancing consumer satisfaction. The chain's "Everyday Low Pricing" strategy is pivotal to its profitability, drawing in cost-conscious customers and fostering high sales volume. By maintaining streamlined operations and a customer-centric approach, Cosmos cultivates a symbiotic relationship between growth and efficiency, allowing it to thrive in a competitive market and continue its expansion across Japan.
See Also
What is Cosmos Pharmaceutical Corp's Cash Interest Paid?
Cash Interest Paid
379m
JPY
Based on the financial report for Feb 28, 2026, Cosmos Pharmaceutical Corp's Cash Interest Paid amounts to 379m JPY.
What is Cosmos Pharmaceutical Corp's Cash Interest Paid growth rate?
Cash Interest Paid CAGR 10Y
19%
Over the last year, the Cash Interest Paid growth was 133%. The average annual Cash Interest Paid growth rates for Cosmos Pharmaceutical Corp have been 99% over the past three years , 43% over the past five years , and 19% over the past ten years .